Clinical Trial Update: Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) [Phase 2]

View source ↗

Summary

Phase 2 long-term follow-up trial to evaluate durability of response to Bepirovirsen in previous Hepatitis B study participants; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Bepirovirsen

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: RECRUITING